Michael Trettel

Array ( [id] => 9295374 [patent_doc_number] => 20140039008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'METHODS FOR THE ADMINISTRATION OF ILOPERIDONE' [patent_app_type] => utility [patent_app_number] => 14/044183 [patent_app_country] => US [patent_app_date] => 2013-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10235 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14044183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9370859 [patent_doc_number] => 20140080732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-20 [patent_title] => 'BLOOD TRANSCRIPTIONAL SIGNATURE OF ACTIVE VERSUS LATENT MYCOBACTERIUM TUBERCULOSIS INFECTION' [patent_app_type] => utility [patent_app_number] => 14/024142 [patent_app_country] => US [patent_app_date] => 2013-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 30858 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14024142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9339541 [patent_doc_number] => 20140066323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-06 [patent_title] => 'CANCER DIAGNOSTICS USING BIOMARKERS' [patent_app_type] => utility [patent_app_number] => 13/968838 [patent_app_country] => US [patent_app_date] => 2013-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 67 [patent_figures_cnt] => 67 [patent_no_of_words] => 112224 [patent_no_of_claims] => 184 [patent_no_of_ind_claims] => 101 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13968838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9561907 [patent_doc_number] => 20140179620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-26 [patent_title] => 'GENE EXPRESSION MARKERS FOR INFLAMMATORY BOWEL DISEASE' [patent_app_type] => utility [patent_app_number] => 13/964861 [patent_app_country] => US [patent_app_date] => 2013-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 196 [patent_figures_cnt] => 196 [patent_no_of_words] => 49463 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13964861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10628944 [patent_doc_number] => 09347090 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-24 [patent_title] => 'Method for determining severity and progression of periodontal disease' [patent_app_type] => utility [patent_app_number] => 13/962637 [patent_app_country] => US [patent_app_date] => 2013-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7539 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 251 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13962637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9634399 [patent_doc_number] => 20140212507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-31 [patent_title] => 'METHOD FOR DETERMINING A THERAPEUTIC APPROACH FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD)' [patent_app_type] => utility [patent_app_number] => 13/955502 [patent_app_country] => US [patent_app_date] => 2013-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 9934 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13955502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10291078 [patent_doc_number] => 20150176077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-25 [patent_title] => 'METHODS FOR PREDICTING WHETHER A SUBJECT IS AT RISK OF DEVELOPING A FOLLICULAR LYMPHOMA' [patent_app_type] => utility [patent_app_number] => 14/416137 [patent_app_country] => US [patent_app_date] => 2013-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5201 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14416137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14327057 [patent_doc_number] => 10294533 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-21 [patent_title] => Microarray slide for detecting toxic algae, barcodes of DNA, hybridisation solution and method of detecting toxic algae [patent_app_type] => utility [patent_app_number] => 14/904393 [patent_app_country] => US [patent_app_date] => 2013-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 6 [patent_no_of_words] => 8580 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 453 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14904393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10226305 [patent_doc_number] => 20150111298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-23 [patent_title] => 'Method for Producing Recombinant 11-De-O-Methyltomaymycin' [patent_app_type] => utility [patent_app_number] => 14/401109 [patent_app_country] => US [patent_app_date] => 2013-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10721 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14401109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10219796 [patent_doc_number] => 20150104789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-16 [patent_title] => 'ANTIBIOTIC SUSCEPTIBILITY TESTING USING PROBES FOR PRERIBOSOMAL RNA' [patent_app_type] => utility [patent_app_number] => 14/398725 [patent_app_country] => US [patent_app_date] => 2013-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11786 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14398725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9160972 [patent_doc_number] => 20130309249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-21 [patent_title] => 'MATERIALS AND METHODS FOR THE PROPHYLACTIC TREATMENT OF A PRE-MALIGNANT CONDITION' [patent_app_type] => utility [patent_app_number] => 13/869796 [patent_app_country] => US [patent_app_date] => 2013-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 66 [patent_figures_cnt] => 66 [patent_no_of_words] => 16907 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13869796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14732009 [patent_doc_number] => 10385395 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-08-20 [patent_title] => Diagnostic tools for response to 6-thiopurine therapy [patent_app_type] => utility [patent_app_number] => 14/391814 [patent_app_country] => US [patent_app_date] => 2013-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 25 [patent_no_of_words] => 18299 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14391814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9205886 [patent_doc_number] => 20140005063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-02 [patent_title] => 'METHOD FOR DETECTING RISK OF PROGRESSION OF LOW GRADE CERVICAL DYSPLASIA' [patent_app_type] => utility [patent_app_number] => 13/854764 [patent_app_country] => US [patent_app_date] => 2013-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17670 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13854764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9896027 [patent_doc_number] => 20150051227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-19 [patent_title] => 'PREDICTIVE BIOMARKER USEFUL FOR CANCER THERAPY MEDIATED BY A CDK INHIBITOR' [patent_app_type] => utility [patent_app_number] => 14/388385 [patent_app_country] => US [patent_app_date] => 2013-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17035 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14388385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8977212 [patent_doc_number] => 20130210642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'Hybridization-Mediated Analysis Of Polymorphisms' [patent_app_type] => utility [patent_app_number] => 13/845496 [patent_app_country] => US [patent_app_date] => 2013-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10368 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13845496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15228171 [patent_doc_number] => 10501800 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-10 [patent_title] => Breast cancer prognosis [patent_app_type] => utility [patent_app_number] => 13/843482 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 75 [patent_no_of_words] => 27275 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13843482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10248313 [patent_doc_number] => 20150133309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-14 [patent_title] => 'Compositions and Methods for Diagnosing and Treating Neoplasia' [patent_app_type] => utility [patent_app_number] => 14/389484 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 30899 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14389484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12368094 [patent_doc_number] => 09957567 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-01 [patent_title] => Methods relating to DENND1A Variant 2 and polycystic ovary syndrome [patent_app_type] => utility [patent_app_number] => 14/402134 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 11428 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14402134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9135732 [patent_doc_number] => 20130296447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-07 [patent_title] => 'Method of Preventing Neurodevelopmental Damage Due to Prenatal Exposure to Environmental Toxins' [patent_app_type] => utility [patent_app_number] => 13/830602 [patent_app_country] => US [patent_app_date] => 2013-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1950 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13830602 [rel_patent_id] =>[rel_patent_doc_number] =>)